Laredo Petroleum, Inc. (NYSE:LPI)

Laredo Petroleum Holdings, Inc. is engaged in the exploration, development and acquisition of oil and natural gas properties in the Permian and Mid-Continent regions of the United States. Laredo Petroleum Holdings, Inc. is headquartered in Tulsa, Oklahoma.

Laredo Petroleum, Inc. (NYSE:LPI)’s Financial Overview

Laredo Petroleum, Inc. (NYSE:LPI) surged 15.95% yesterday to close its trading session at $15.99. The company has 1 year Price Target of $13.8. Laredo Petroleum, Inc. has 52-Week high of $16.33 and 52-Week Low of $3.9. The stock touched its 52-Week High on Nov 23, 2016 and 52-Week Low on Feb 19, 2016. The stock traded with the volume of 7.95 Million shares yesterday. The firm shows the market capitalization of $3.87 Billion.

Laredo Petroleum, Inc. (NYSE:LPI) reported its last quarterly earnings on Sep 16 where the firm reported its Actual EPS of $0.12/share against the analyst consensus estimate of $0.12/share. The difference between the actual and expected EPS is $0 a share with a surprise factor of 0%.

The firm is trading with SMA20 of 16.96 Percent, SMA50 of 22.06 Percent and SMA200 of 45.57 percent. Laredo Petroleum, Inc. has P/S value of 7.21 while its P/B value stands at 19.99. Similarly, the company has Return on Assets of -70.8 percent, Return on Equity of 0 percent and Return on Investment of -150.3 Percent. The company shows Gross Margin and Operating Margin of 48.5 percent and 0 percent respectively.

Many brokerage firms are involved in issuing their ratings on Laredo Petroleum, Inc. (NYSE:LPI). On 13-Oct-16 Credit Suisse Downgrade Laredo Petroleum, Inc. Stock  to Underperform. Another firm also rated the stock on 13-Sep-16 where FBR & Co. Initiated the stock to Outperform.

The Stock currently has Analyst’ mean Recommendation of 2.7 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 25 analysts offering 12-month price forecasts for Laredo Petroleum Inc have a median target of 14.00, with a high estimate of 20.00 and a low estimate of 3.00. The median estimate represents a -12.45% decrease from the last price of 15.99.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

Sophiris Bio, Inc. (NASDAQ:SPHS)

Sophiris Bio Inc. operates as a biopharmaceutical company. The Company is developing a treatment for benign prostatic hyperplasia (BPH or enlarged prostate). It has operations based in San Diego. Sophiris Bio Inc. is based in Canada.

Sophiris Bio, Inc. (NASDAQ:SPHS)’s Financial Outlook

The 4 analysts offering 12-month price forecasts for Sophiris Bio Inc have a median target of 7.50, with a high estimate of 8.00 and a low estimate of 6.00. The median estimate represents a +171.74% increase from the last price of 2.76.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

According to Zacks Investment Research, Sophiris Bio, Inc. has a Consensus Recommendation of 1. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock fell -8.31% and closed its last trading session at $2.76. The company has the market capitalization of $83.1 Million. The stock has 52-week high of $8.55 and 52-Week low of $0.8. The firm touched its 52-Week high on Jul 26, 2016 and 52-Week low on May 23, 2016. The company has volume of 1.34 Million shares. The company has a total of 30.11 Million shares outstanding.

Sophiris Bio, Inc. (NASDAQ:SPHS) in the last quarter reported its actual EPS of $-0.17/share where the analyst estimated EPS was $-0.1/share. The difference between the actual and Estimated EPS is $-0.07. This shows a surprise factor of -70 percent.

The company has YTD performance of 55.06 percent. Beta for Sophiris Bio, Inc. stands at 2.12 while its ATR (average true range) is 0.2. The company has Weekly Volatility of 8.27%% and Monthly Volatility of 8.11%%.

Sophiris Bio, Inc. has distance from 20-day Simple Moving Average (SMA20) of 2.01%, Distance from 50-Day Simple Moving Average of -3.99 percent and Distance from 200-Day Simple Moving Average of 10.53%.

The Company currently has ROA (Return on Assets) of -95.3 percent, Return on Equity (ROE) of -308.3 Percent and Return on Investment (ROI) of 0% with Gross margin of 0 percent and Operating & Profit margin of 0% and 0% respectively.